| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT05777499 MUSic Therapy In Complex Specialist Neurorehabilitation |
Trial completed |
| 2026-08-13 | NCT05777499 MUSic Therapy In Complex Specialist Neurorehabilitation |
date change Primary completion pushed: 2025-06 -> 2026-02-01 |
| 2026-08-13 | NCT05777499 MUSic Therapy In Complex Specialist Neurorehabilitation |
date change Completion pushed: 2025-10 -> 2026-02-28 |
| 2026-08-12 | NCT05544526 CAR T Cells to Target GD2 for DMG |
date change Primary completion pushed: 2025-12 -> 2027-08 |
| 2026-08-12 | NCT05544526 CAR T Cells to Target GD2 for DMG |
date change Completion pushed: 2039-12 -> 2042-08 |
| 2026-08-12 | NCT05391490 Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor… |
Recruitment opened |
| 2026-08-12 | NCT05391490 Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor… |
date change Primary completion pushed: 2024-11 -> 2027-02 |
| 2026-08-12 | NCT05391490 Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor… |
date change Completion pushed: 2034-11 -> 2040-02 |
| 2026-08-09 | NCT05361135 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus… |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-05 | NCT07549893 Middle Meningeal Artery Coagulation During Burr-Hole Drainage for Chronic Subdural… |
Recruitment opened |
| 2026-08-05 | NCT06778122 In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors |
Trial completed |
| 2026-08-05 | NCT06778122 In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors |
date change Primary completion moved earlier: 2026-07-31 -> 2026-06-19 |
| 2026-07-30 | NCT07135271 BeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer |
Recruitment opened |
| 2026-07-24 | NCT07717632 AI-enhanced LF-MRI in Epilepsy |
Primary endpoint(s) modified |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-07 | NCT07751133 Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer | Phase 3 | Not Yet Recruiting |
| 2026-08-07 | NCT07751380 Multi-modular Chimeric Antigen Receptor T Cells tarGeting B7-H3 in Children, Teenage &… | Phase 1 | Recruiting |
| 2026-07-24 | NCT07726693 Apixaban to Prevent Decompensation of Early Liver Cirrhosis Trial | Phase 3 | Not Yet Recruiting |
| 2026-07-23 | NCT07724132 An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic… | Phase 3 | Recruiting |
| 2026-07-21 | NCT07717632 AI-enhanced LF-MRI in Epilepsy | Active, Not Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT03288532 | Renal Adjuvant MultiPle Arm Randomised Trial | Renal Cell Carcinoma | Recruiting |
| NCT05405868 | Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase… | Glaucoma, Open-Angle | Recruiting |
| NCT05778617 | Ambroxol to Slow Progression in Parkinson Disease | Parkinson Disease | Recruiting |
| NCT06320067 | A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive… | Prostate Cancer Metastatic | Recruiting |
| NCT07207057 | Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm… | Parkinsons Disease (PD) | Recruiting |
| NCT04685616 | Brentuximab Vedotin in Early Stage Hodgkin Lymphoma | Hodgkin Lymphoma | Recruiting |
| NCT07724132 | An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic… | Alzheimer's Disease (AD) | Recruiting |
| NCT02544308 | Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma | Plasmacytoma | Active, Not Recruiting |
| NCT00943423 | PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage… | Lymphoma | Active, Not Recruiting |
| NCT06242782 | Vertical Ridge Augmentation Strategies | Alveolar Bone Resorption | Not Yet Recruiting |
| NCT01566240 | Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced… | Cervical Cancer | Active, Not Recruiting |
| NCT05073835 | Semaglutide 2.4 mg in Patients With Poor Weight-loss | Obesity | Active, Not Recruiting |
| NCT02804815 | Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival… | Cancer | Active, Not Recruiting |
| NCT07163143 | Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed… | Tuberculosis (TB) | Not Yet Recruiting |
| NCT07726693 | Apixaban to Prevent Decompensation of Early Liver Cirrhosis Trial | Liver Cirrhosis | Not Yet Recruiting |
| NCT07751133 | Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer | Prostate Cancer | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT04061512 | Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC)… | Waldenstrom Macroglobulinemia | Recruiting |
| NCT01398085 | IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer… | Thyroid Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT05080556 | Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive… | Ovarian Cancer | Recruiting |
| NCT05185739 | Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) | Hepatocellular Carcinoma | Recruiting |
| NCT06071871 | A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell… | Large B-cell Lymphoma | Recruiting |
| NCT05635162 | Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma | Mantle Cell Lymphoma | Recruiting |
| NCT06762769 | Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma | Smouldering Myeloma | Recruiting |
| NCT06114628 | Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB | Pulmonary Tuberculosis | Recruiting |
| NCT05197322 | NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer | Adenocarcinoma of the Colon | Recruiting |